| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | $10.79M | $2.39M | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $123.83M | $114.02M | $61.14M | $45.24M | $19.58M |
| R&D | $104.89M | $93.80M | $42.32M | $32.36M | $12.30M |
| SG&A | $18.95M | $20.22M | $18.82M | $12.88M | $7.28M |
| Operating Income | -$123.83M | -$114.02M | -$61.14M | -$45.24M | -$19.58M |
| Interest Expense | – | – | $581.00K | $0.00 | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$121.33M | -$102.33M | -$52.37M | -$42.86M | -$100.61M |
| EPS (basic) | -2.0000 | -1.7100 | -1.0800 | -1.0600 | -5.0200 |
| EPS (diluted) | -2.0000 | -1.7100 | -1.0800 | -1.0600 | -5.0200 |
| Shares (diluted) | $60.56M | $60.01M | $48.61M | $40.60M | $20.06M |